Glucose-lowering effect of berberine on type 2 diabetes: A systematic review and meta-analysis
暂无分享,去创建一个
Yaomin Xu | Kaijian Hou | Rong-ping Chen | Yi Zhang | Ningning Xu | Wenting Xie | Yan Chen | F. Su | Guizhong Wang | Zichong Peng | Zhuping Hu
[1] Dongya Zhang,et al. Microbiota in health and diseases , 2022, Signal Transduction and Targeted Therapy.
[2] E. Huang,et al. 6. Glycemic Targets: Standards of Medical Care in Diabetes-2022. , 2021, Diabetes care.
[3] Pingna Zhang,et al. The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2021, Oxidative Medicine and Cellular Longevity.
[4] B. Duncan,et al. IDF diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045 , 2021, Diabetes Research and Clinical Practice.
[5] Haixia Huang,et al. Berberine is an insulin secretagogue targeting the KCNH6 potassium channel , 2021, Nature Communications.
[6] S. Funghetto,et al. Comparative evaluation of inflammatory parameters and substitute insulin resistance indices in elderly women with and without type 2 diabetes mellitus , 2021, Experimental Gerontology.
[7] J. Halcox,et al. Glucagon‐like peptide‐1 receptor agonists improve biomarkers of inflammation and oxidative stress: A systematic review and meta‐analysis of randomised controlled trials , 2021, Diabetes, obesity & metabolism.
[8] Zhou Rui,et al. [Research progress on chemical compositions of Coptidis Rhizoma and pharmacological effects of berberine]. , 2020, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[9] Chien-Ju Lin,et al. Therapeutic Effects of BCG Vaccination on Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Randomized Controlled Trials , 2020, Journal of diabetes research.
[10] Yanwei Xing,et al. Effect of Berberine on Atherosclerosis and Gut Microbiota Modulation and Their Correlation in High-Fat Diet-Fed ApoE−/− Mice , 2020, Frontiers in Pharmacology.
[11] J. Garber,et al. CONSENSUS STATEMENT BY THE AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY ON THE COMPREHENSIVE TYPE 2 DIABETES MANAGEMENT ALGORITHM - 2020 EXECUTIVE SUMMARY. , 2020, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[12] S. Shyng,et al. Ion Channels of the Islets in Type 2 Diabetes. , 2020, Journal of molecular biology.
[13] Wencong Lu,et al. Mechanisms and characteristics of sulfonylureas and glinides. , 2019, Current topics in medicinal chemistry.
[14] Jun-Da Tu,et al. [Compound traditional Chinese medicine in treatment of diabetes]. , 2019, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.
[15] Ruoling Chen,et al. Effects of berberine on blood glucose in patients with type 2 diabetes mellitus: a systematic literature review and a meta-analysis. , 2019, Endocrine journal.
[16] S. Latifi,et al. The Effects of Active Ingredients of Barberry Root (Berberine) on Glycemic Control and Insulin Resistance in Type 2 Diabetic Patients , 2018 .
[17] M. Antal,et al. Glycogen phosphorylase inhibition improves beta cell function , 2018, British journal of pharmacology.
[18] T. Bai,et al. Geniposide acutely stimulates insulin secretion in pancreatic β-cells by regulating GLP-1 receptor/cAMP signaling and ion channels , 2016, Molecular and Cellular Endocrinology.
[19] M. Kakei,et al. Glucose and GTP-binding protein-coupled receptor cooperatively regulate transient receptor potential-channels to stimulate insulin secretion [Review]. , 2016, Endocrine journal.
[20] G. Isbister,et al. Treatment of sulfonylurea and insulin overdose. , 2016, British journal of clinical pharmacology.
[21] H. Car,et al. Antidiabetic drugs and risk of cancer , 2015, Pharmacological reports : PR.
[22] G. Hatch,et al. Berberine as a therapy for type 2 diabetes and its complications: From mechanism of action to clinical studies. , 2015, Biochemistry and cell biology = Biochimie et biologie cellulaire.
[23] Yanyun Zhao,et al. Meta-analysis of the effect and safety of berberine in the treatment of type 2 diabetes mellitus, hyperlipemia and hypertension. , 2015, Journal of ethnopharmacology.
[24] P. Berggren,et al. Ionic mechanisms in pancreatic β cell signaling , 2014, Cellular and Molecular Life Sciences.
[25] J. Levy,et al. The effect of glibenclamide on insulin secretion at normal glucose concentrations , 2014, Diabetologia.
[26] Hualiang Jiang,et al. Natural product vindoline stimulates insulin secretion and efficiently ameliorates glucose homeostasis in diabetic murine models. , 2013, Journal of ethnopharmacology.
[27] F. Lu,et al. Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis , 2012, Evidence-based complementary and alternative medicine : eCAM.
[28] G. Marchesini,et al. Pilot study on the additive effects of berberine and oral type 2 diabetes agents for patients with suboptimal glycemic control , 2012, Diabetes, metabolic syndrome and obesity : targets and therapy.
[29] C. Nichols,et al. Block of Kv1.7 potassium currents increases glucose-stimulated insulin secretion , 2012, EMBO molecular medicine.
[30] C. Richards,et al. Emergency hospitalizations for adverse drug events in older Americans. , 2011, The New England journal of medicine.
[31] J. Chen,et al. Effect of traditional Chinese medicine berberine on type 2 diabetes based on comprehensive metabonomics. , 2010, Talanta.
[32] Ye Wen-ping. CLINICAL EFFICACY OF BERBERINE TREATMENT OF DIABETES , 2010 .
[33] Weiliang Zhu,et al. [Advances in the study of berberine and its derivatives]. , 2008, Yao xue xue bao = Acta pharmaceutica Sinica.
[34] G. Ning,et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. , 2008, The Journal of clinical endocrinology and metabolism.
[35] L. Qun. Effects of berberine and pioglitazone on type 2 diabetes acute insulin secretion and adiponectin , 2008 .
[36] Hu Qi-ming. Effect of Berberine on Islet β-cell Function in Type 2 Diabetes Mellitus (Damp-Heat Type) , 2008 .
[37] P. Gilon,et al. G Protein-independent Activation of an Inward Na+Current by Muscarinic Receptors in Mouse Pancreatic β-Cells* , 2002, The Journal of Biological Chemistry.
[38] R. Pratley,et al. The role of impaired early insulin secretion in the pathogenesis of Type II diabetes mellitus , 2001, Diabetologia.
[39] J. Ligtenberg,et al. Effect of glibenclamide on insulin release at moderate and high blood glucose levels in normal man , 1997, European journal of clinical investigation.